ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

N4P N4 Pharma Plc

0.825
0.00 (0.00%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma Plc LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.825 0.80 0.85 0.85 0.80 0.80 3,285,001 15:54:08
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Drug & Proprietary Stores 0 -1.03M -0.0057 -1.44 1.48M

N4 Pharma PLC Holding(s) in Company (8605G)

01/06/2017 11:02am

UK Regulatory


TIDMN4P

RNS Number : 8605G

N4 Pharma PLC

01 June 2017

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES (i) 
 
 
 
 1. Identity of the issuer or                                         N4 PHARMA PLC 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
-----------------------------------------------------------  ---------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
----------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights 
------------------------------------------------------------  --------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
------------------------------------------------------------  --------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
------------------------------------------------------------  --------------------- 
 An event changing the breakdown of voting rights                       X 
------------------------------------------------------------  --------------------- 
 Other (please 
  specify): 
----------------------------------------------------------    --------------------- 
 3. Full name of person(s)                                     NIGEL JAMES THEOBALD 
  subject to the 
  notification obligation: 
  (iii) 
-----------------------------------------------------------  ---------------------- 
 4. Full name of shareholder(s) 
  (if different from 3.):(iv) 
-----------------------------------------------------------  ---------------------- 
 5. Date of the transaction                                             23 MAY 2017 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
-----------------------------------------------------------  ---------------------- 
 6. Date on which issuer                                               01 JUNE 2017 
  notified: 
-----------------------------------------------------------  ---------------------- 
 7. Threshold(s) that is/are 
  crossed or 
  reached: (vi, vii)                                                            17% 
-----------------------------------------------------------  ---------------------- 
 
 
 
 8. Notified details: 
---------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
---------------------------------------------------------------------------------------------------------------------- 
 Class/type     Situation previous                Resulting situation after the 
  of             to the triggering                 triggering transaction 
  shares         transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
-------------  --------------------------------  --------------------------------------------------------------------- 
                Number           Number           Number         Number of                    % of voting 
                 of               of               of shares      voting                       rights (x) 
                 Shares           Voting                          rights 
                                  Rights 
-------------  ---------------  ---------------  -------------  ---------------------------  ------------------------- 
                                                  Direct         Direct         Indirect      Direct        Indirect 
                                                                  (xi)           (xii) 
-------------      -----------    -----------    -------------  -------------  ------------  ------------  ----------- 
 GB00BYW8QM32   12,198,577       12,198,577       17.01%         12,198,577                   16.82% 
               ---------------  ---------------  -------------  -------------  ------------  ------------  ----------- 
 
 
 B: Qualifying Financial Instruments 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of            Expiration     Exercise/                       Number of voting               % of voting 
 financial           date           Conversion                      rights that                    rights 
 instrument          (xiii)         Period (xiv)                    may be 
                                                                    acquired if 
                                                                    the 
                                                                    instrument 
                                                                    is 
                                                                    exercised/ 
                                                                    converted. 
-----------------  -------------  ------------------------------  -----------------------------  --------------------- 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of          Exercise       Expiration     Exercise/        Number of voting               % of voting 
 financial         price         date           Conversion        rights instrument              rights (xix, 
 instrument                      (xvii)         period            refers to                      xx) 
                                                (xviii) 
---------------  -------------  -------------  ---------------  -----------------------------  ----------------------- 
                                                                                                Nominal       Delta 
---------------  -------------  -------------  ---------------  -----------------------------  ------------  --------- 
 
 
 Total (A+B+C) 
---------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                            Percentage of voting rights 
-------------------------------------------------  ------------------------------------------------------------------- 
 12,198,577                                         16.82% 
-------------------------------------------------  ------------------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
---------------------------------------------------------------------------------------------- 
 
 
 Proxy Voting: 
---------------------------------------------------------------------------------------------- 
 10. Name of the proxy holder: 
-------------------------------------------------------------  ------------------------------- 
 11. Number of voting rights proxy 
  holder will cease 
  to hold: 
-------------------------------------------------------------  ------------------------------- 
 12. Date on which proxy holder will 
  cease to hold 
  voting rights: 
-------------------------------------------------------------  ------------------------------- 
 
 
  13. Additional information:                                   The Company's issued share 
                                                                capital increased on 23 May 
                                                                2017 as a result of exercises 
                                                                of warrants 
-------------------------------------------------------------  ------------------------------- 
 14. Contact name:                                                              Nigel Theobald 
-------------------------------------------------------------  ------------------------------- 
 15. Contact telephone number:                                                + 44 1332 690061 
-------------------------------------------------------------  ------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLLIFEARAILIID

(END) Dow Jones Newswires

June 01, 2017 06:02 ET (10:02 GMT)

1 Year N4 Pharma Chart

1 Year N4 Pharma Chart

1 Month N4 Pharma Chart

1 Month N4 Pharma Chart

Your Recent History

Delayed Upgrade Clock